• 
  Fusion Antibodies (AIM: #FAB) provides a year-end trading update; https://t.co/G8QIrgYLmu
• 
  Omega Diagnostics (AIM: #ODX) provides a trading update, with results for the year ended 31 March 2019 will be in l… https://t.co/s3TTy8z21o
• 
  @LiDCOLtd (AIM: #LID) has received regulatory approval for LiDCOrapidV3 for sale in South Korea, the 4th largest me… https://t.co/cFcRHZLWwQ